Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Primary chemoprevention of familial adenomatous polyposis with sulindac.

Giardiello FM, Yang VW, Hylind LM, Krush AJ, Petersen GM, Trimbath JD, Piantadosi S, Garrett E, Geiman DE, Hubbard W, Offerhaus GJ, Hamilton SR.

N Engl J Med. 2002 Apr 4;346(14):1054-9.

2.

Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis.

Giardiello FM, Casero RA Jr, Hamilton SR, Hylind LM, Trimbath JD, Geiman DE, Judge KR, Hubbard W, Offerhaus GJ, Yang VW.

Gastroenterology. 2004 Feb;126(2):425-31.

3.

Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis.

Giardiello FM, Spannhake EW, DuBois RN, Hylind LM, Robinson CR, Hubbard WC, Hamilton SR, Yang VW.

Dig Dis Sci. 1998 Feb;43(2):311-6.

4.

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJ.

N Engl J Med. 1993 May 6;328(18):1313-6.

5.

Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis.

Guldenschuh I, Hurlimann R, Muller A, Ammann R, Mullhaupt B, Dobbie Z, Zala GF, Flury R, Seelentag W, Roth J, Meyenberger C, Fried M, Hoppeler T, Spigelman AD, Scott RJ.

Dis Colon Rectum. 2001 Aug;44(8):1090-7; discussion 1097-9.

PMID:
11535846
6.

Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis.

Winde G, Schmid KW, Brandt B, Müller O, Osswald H.

Dis Colon Rectum. 1997 Oct;40(10):1156-68; discussion 1168-9.

PMID:
9336110
8.

Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis.

Hisamuddin IM, Wehbi MA, Chao A, Wyre HW, Hylind LM, Giardiello FM, Yang VW.

Clin Cancer Res. 2004 Dec 15;10(24):8357-62.

9.

Tissue prostanoids as biomarkers for chemoprevention of colorectal neoplasia: correlation between prostanoid synthesis and clinical response in familial adenomatous polyposis.

Yang VW, Geiman DE, Hubbard WC, Spannhake EW, Hylind LM, Hamilton SR, Giardiello FM.

Prostaglandins Other Lipid Mediat. 2000 Jan;60(1-3):83-96.

10.

Sulindac induced regression of colorectal adenomas in familial adenomatous polyposis: evaluation of predictive factors.

Giardiello FM, Offerhaus JA, Tersmette AC, Hylind LM, Krush AJ, Brensinger JD, Booker SV, Hamilton SR.

Gut. 1996 Apr;38(4):578-81.

11.

Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study.

Cruz-Correa M, Hylind LM, Romans KE, Booker SV, Giardiello FM.

Gastroenterology. 2002 Mar;122(3):641-5.

PMID:
11874996
12.

Effect of the non-steroidal anti-inflammatory drug sulindac on colorectal adenomas of uncolectomized familial adenomatous polyposis.

Matsumoto T, Nakamura S, Esaki M, Yao T, Iida M.

J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 2):251-7.

PMID:
16460482
13.

[Treatment with sulindac of adenomatous polyps in familial polyposis].

Cerdán FJ, Torres-Melero J, Martínez S, Gutiérrez del Olmo A, Balibrea JL.

Rev Esp Enferm Dig. 1995 Aug;87(8):574-6. Spanish.

PMID:
7577106
14.

Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac.

Keller JJ, Offerhaus GJ, Polak M, Goodman SN, Zahurak ML, Hylind LM, Hamilton SR, Giardiello FM.

Gut. 1999 Dec;45(6):822-8.

15.

[Chemoprevention of familial cancer].

Ishikawa H.

Gan To Kagaku Ryoho. 1997 Jun;24(8):951-7. Review. Japanese.

PMID:
9212803
16.

Sulindac in familial adenomatous polyposis.

Levy R.

N Engl J Med. 2002 Aug 22;347(8):615. No abstract available.

17.

Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.

Koornstra JJ, Rijcken FE, Oldenhuis CN, Zwart N, van der Sluis T, Hollema H, deVries EG, Keller JJ, Offerhaus JA, Giardiello FM, Kleibeuker JH.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1608-12.

18.

Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac.

Nugent KP, Spigelman AD, Phillips RK.

Dis Colon Rectum. 1996 Jun;39(6):659-62.

PMID:
8646953
19.

Effect of sulindac treatment for attenuated familial adenomatous polyposis with a new germline APC mutation at codon 161: report of a case.

Esaki M, Matsumoto T, Mizuno M, Kobori Y, Yoshimura R, Yao T, Iida M.

Dis Colon Rectum. 2002 Oct;45(10):1397-402; discussion 1402-6.

PMID:
12394442
20.

Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis.

Hisamuddin IM, Wehbi MA, Schmotzer B, Easley KA, Hylind LM, Giardiello FM, Yang VW.

Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2366-9.

Supplemental Content

Support Center